Estimaciones de analistas de Wall Street para Moleculin Biotech, Inc. (MBRX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-0.44 | ||
| 2026-08-13 | $-1.40 | $-1.55 | +9.7% |
| 2026-05-14 | $-3.54 | $-1.69 | -109.5% |
| 2026-03-20 | $2.61 | $-7.77 | +133.6% |
| 2025-11-13 | $-17.02 | $-5.00 | -240.4% |
| 2025-08-12 | $-12.25 | $-9.75 | -25.6% |
| 2025-05-14 | $-17.25 | $-17.75 | +2.8% |
| 2025-03-24 | $-6.25 | $-1.54 | -305.8% |
Ratios de valoración
| Precio / Valor contable | 0.37 |
| EV / EBITDA | 0.10 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $6162 | $18000 | $68000 | $185000 | 0 | 0 | 0 | 0 | 0 | $90000 |
| Beneficio Bruto | -$6162 | -$18000 | -$68000 | -$185000 | 0 | 0 | 0 | 0 | 0 | -$90000 |
| I+D | $1.5M | $4.5M | $9.7M | $11.0M | $12.8M | $14.4M | $19.0M | $19.5M | $17.7M | $15.9M |
| Generales y Administrativos | $2.4M | $4.1M | $5.3M | $6.3M | $6.8M | $8.4M | $11.5M | $10.0M | $8.8M | $9.1M |
| Gastos Operativos | $3.9M | $8.7M | $15.0M | $17.3M | $19.7M | $23.0M | $30.6M | $29.6M | $26.6M | $25.1M |
| Beneficio Operativo | -$3.9M | -$8.7M | -$15.0M | -$17.5M | -$19.7M | -$23.0M | -$30.6M | -$29.6M | -$26.6M | -$25.1M |
| EBITDA | -$3.9M | -$8.6M | -$15.0M | -$13.2M | -$19.5M | -$15.7M | -$28.9M | -$29.6M | -$21.6M | -$33.5M |
| Gastos por Intereses | $43214 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$3.9M | -$9.8M | -$11.9M | -$13.4M | -$17.4M | -$15.9M | -$29.0M | -$29.8M | -$21.8M | -$33.6M |
| Impuestos | 0 | 0 | 0 | -$229000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$3.9M | -$9.8M | -$11.9M | -$13.2M | -$17.4M | -$15.9M | -$29.0M | -$29.8M | -$21.8M | -$33.6M |
| BPA | $-900.00 | $-1188.07 | $-1031.54 | $-729.63 | $-661.00 | $-221.77 | $-380.51 | $-376.71 | $-189.14 | $-28.42 |
| BPA Diluido | $-900.00 | $-1188.07 | $-1031.54 | $-729.63 | $-661.00 | $-221.77 | $-380.51 | $-376.71 | $-189.14 | $-28.42 |
| Acciones en Circulación (Diluidas) | $4367 | $8252 | $11512 | $18098 | $26255 | $71669 | $76278 | $79024 | $137720 | $1.2M |
Precio
| Precio | $0.74 |
| Capitalización | $4M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ADAP · AIMD · APLM · ATHA · BLRX · CTXR · ICU
Explorar sector: Healthcare · Biotechnology
Más secciones de MBRX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones